Published in J Clin Sleep Med on October 15, 2006
Circadian Misalignment in Inflammatory Bowel Disease | NCT04637399
Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol (2013) 1.83
Characterization of relations among sleep, inflammation, and psychiatric dysfunction in depressed youth with Crohn disease. J Pediatr Gastroenterol Nutr (2013) 1.82
Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med (2009) 1.75
Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol (2014) 1.70
Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion (2011) 1.49
Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol (2010) 1.01
Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol (2011) 0.94
Sleep and inflammatory bowel disease: exploring the relationship between sleep disturbances and inflammation. Gastroenterol Hepatol (N Y) (2013) 0.93
Parent and self-report of sleep-problems and daytime tiredness among adolescents with inflammatory bowel disease and their population-based controls. Sleep (2010) 0.90
Neurological disorders and inflammatory bowel diseases. World J Gastroenterol (2014) 0.86
The potential role of a self-management intervention for ulcerative colitis: a brief report from the ulcerative colitis hypnotherapy trial. Biol Res Nurs (2011) 0.85
Endogenous melatonin profiles in asymptomatic inflammatory bowel disease. Scand J Gastroenterol (2010) 0.80
High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease. Dig Dis Sci (2015) 0.79
Impaired sleep quality in Crohn's disease depends on disease activity. Dig Dis Sci (2013) 0.78
Environmental risk factors for inflammatory bowel diseases: Evidence based literature review. World J Gastroenterol (2016) 0.76
Melatonin improves experimental colitis with sleep deprivation. Int J Mol Med (2015) 0.75
Gastrointestinal motility during sleep assessed by tracking of telemetric capsules combined with polysomnography - a pilot study. Clin Exp Gastroenterol (2015) 0.75
Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci (2016) 0.75
Quality of life in inflammatory bowel disease patients: A cross-sectional study. J Res Med Sci (2017) 0.75
Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group. Sleep (2004) 6.12
Cognitive behavioral therapy for insomnia improves sleep and decreases pain in older adults with co-morbid insomnia and osteoarthritis. J Clin Sleep Med (2009) 2.05
Intestinal barrier: an interface between health and disease. J Gastroenterol Hepatol (2003) 1.98
Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res (2007) 1.97
Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord (2011) 1.87
Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol (2012) 1.79
Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol (2004) 1.76
Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol (2008) 1.76
Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov Disord (2012) 1.76
Sleep deprivation worsens inflammation and delays recovery in a mouse model of colitis. Sleep Med (2009) 1.75
Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res (2009) 1.75
The scoring of arousal in sleep: reliability, validity, and alternatives. J Clin Sleep Med (2007) 1.71
Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem Biodivers (2010) 1.68
Intestinal permeation and gastrointestinal disease. J Clin Gastroenterol (2002) 1.68
Sleep and quality of life in breast cancer patients. J Pain Symptom Manage (2002) 1.65
Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease. Am J Hematol (2007) 1.53
Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol (2009) 1.52
Is moderate red wine consumption safe in inactive inflammatory bowel disease? Digestion (2011) 1.49
Impact of sleep disturbances in inflammatory bowel disease. J Gastroenterol Hepatol (2007) 1.49
Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk. Clin Gastroenterol Hepatol (2003) 1.46
MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res (2010) 1.44
Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. Liver Int (2008) 1.43
Longitudinal Survey of Microbiota in Hospitalized Preterm Very-Low-Birth-Weight Infants. J Pediatr Gastroenterol Nutr (2016) 1.42
Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One (2011) 1.40
Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. Clin Gastroenterol Hepatol (2007) 1.35
Reactive oxygen species: are they involved in the pathogenesis of GERD, Barrett's esophagus, and the latter's progression toward esophageal cancer? Am J Gastroenterol (2002) 1.24
Lymphogranuloma venereum proctosigmoiditis is a mimicker of inflammatory bowel disease. World J Gastroenterol (2012) 1.23
Retrospective chart review of severe infusion reactions with rituximab, cetuximab, and bevacizumab in community oncology practices: assessment of clinical consequences. Support Care Cancer (2007) 1.20
Adverse effects of chronic circadian desynchronization in animals in a "challenging" environment. Am J Physiol Regul Integr Comp Physiol (2008) 1.20
Disruption of the Circadian Clock in Mice Increases Intestinal Permeability and Promotes Alcohol-Induced Hepatic Pathology and Inflammation. PLoS One (2013) 1.16
Nitric oxide-mediated intestinal injury is required for alcohol-induced gut leakiness and liver damage. Alcohol Clin Exp Res (2009) 1.15
Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis. Arch Gen Psychiatry (2011) 1.13
Recent developments in the classification, evaluation, and treatment of insomnia. Chest (2006) 1.11
Alcohol stimulates activation of Snail, epidermal growth factor receptor signaling, and biomarkers of epithelial-mesenchymal transition in colon and breast cancer cells. Alcohol Clin Exp Res (2009) 1.09
Gas chromatographic method for detection of urinary sucralose: application to the assessment of intestinal permeability. J Chromatogr B Analyt Technol Biomed Life Sci (2003) 1.07
Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom Med (2007) 1.07
Resolution of common dietary sugars from probe sugars for test of intestinal permeability using capillary column gas chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.07
Investing in academic medicine research mentoring: low cost, high return. Gastroenterology (2013) 1.07
Mastocytic enterocolitis: increased mucosal mast cells in chronic intractable diarrhea. Arch Pathol Lab Med (2006) 1.06
CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. Free Radic Biol Med (2013) 1.06
Inpatient capsule endoscopy leads to frequent incomplete small bowel examinations. World J Gastroenterol (2012) 1.05
Influence of dietary fiber on inflammatory bowel disease and colon cancer: importance of fermentation pattern. Nutr Rev (2007) 1.02
Network-based modeling of the human gut microbiome. Chem Biodivers (2010) 1.02
Sorafenib or placebo with either gemcitabine or capecitabine in patients with HER-2-negative advanced breast cancer that progressed during or after bevacizumab. Clin Cancer Res (2013) 1.02
Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol (2010) 1.01
Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8⁺ T cell function in vitro. J Leukoc Biol (2013) 1.01
In vitro characterization of the impact of selected dietary fibers on fecal microbiota composition and short chain fatty acid production. Anaerobe (2013) 1.00
Role of intestinal circadian genes in alcohol-induced gut leakiness. Alcohol Clin Exp Res (2011) 1.00
Phase II clinical trial of bevacizumab with albumin-bound paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma. Gynecol Oncol (2012) 0.99
Circadian phase in delayed sleep phase syndrome: predictors and temporal stability across multiple assessments. Sleep (2006) 0.99
Implications of IV monoclonal antibody infusion reaction for the patient, caregiver, and practice: results of a multicenter study. Support Care Cancer (2008) 0.98
Solid-phase microextraction and the human fecal VOC metabolome. PLoS One (2011) 0.98
Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery. J Gastrointest Surg (2004) 0.98
Apoptosis resistance in ulcerative colitis: high expression of decoy receptors by lamina propria T cells. Eur J Immunol (2006) 0.98
Examining maladaptive beliefs about sleep across insomnia patient groups. J Psychosom Res (2010) 0.97
Heightened responses to stressors in patients with inflammatory bowel disease. Am J Gastroenterol (2005) 0.97
Daytime sleepiness and alertness in patients with Parkinson disease. Sleep (2004) 0.96
β-Catenin promotes colitis and colon cancer through imprinting of proinflammatory properties in T cells. Sci Transl Med (2014) 0.96
Ethanol-induced mast cell-mediated inflammation leads to increased susceptibility of intestinal tumorigenesis in the APC Δ468 min mouse model of colon cancer. Alcohol Clin Exp Res (2013) 0.94
Minimally invasive surgery for achalasia: a 10-year experience. J Gastrointest Surg (2004) 0.94
The scoring of cardiac events during sleep. J Clin Sleep Med (2007) 0.94
Sleep disturbances and inflammatory bowel disease: a potential trigger for disease flare? Expert Rev Clin Immunol (2011) 0.94
Atopic irritable bowel syndrome: a novel subgroup of irritable bowel syndrome with allergic manifestations. Ann Allergy Asthma Immunol (2008) 0.94
Mucosal mast cells are pivotal elements in inflammatory bowel disease that connect the dots: stress, intestinal hyperpermeability and inflammation. World J Gastroenterol (2007) 0.93
Oats supplementation prevents alcohol-induced gut leakiness in rats by preventing alcohol-induced oxidative tissue damage. J Pharmacol Exp Ther (2009) 0.93
Particulate matter air pollution causes oxidant-mediated increase in gut permeability in mice. Part Fibre Toxicol (2011) 0.92
Cap polyposis with protein-losing enteropathy. Gastroenterol Hepatol (N Y) (2011) 0.91
Reconsidering the methodology of "stress" research in inflammatory bowel disease. J Crohns Colitis (2008) 0.91
Chronic alcohol exposure renders epithelial cells vulnerable to bacterial infection. PLoS One (2013) 0.91
PI3K/AKT signaling is essential for communication between tissue-infiltrating mast cells, macrophages, and epithelial cells in colitis-induced cancer. Clin Cancer Res (2013) 0.91
Impact of adherence with positive airway pressure therapy on hypercapnia in obstructive sleep apnea. J Clin Sleep Med (2006) 0.90
Use of herbal preparations in the treatment of oxidant-mediated inflammatory disorders. Complement Ther Med (2006) 0.90
The role of oral hygiene in inflammatory bowel disease. Dig Dis Sci (2010) 0.89
Pain coping strategies for tension-type headache: possible implications for insomnia? J Clin Sleep Med (2009) 0.89
Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review. Support Care Cancer (2011) 0.87
Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn (2007) 0.86
Role of snail activation in alcohol-induced iNOS-mediated disruption of intestinal epithelial cell permeability. Alcohol Clin Exp Res (2011) 0.85
The role of matrix metalloproteinases in intestinal epithelial wound healing during normal and inflammatory states. J Surg Res (2010) 0.85
Laparoscopic wedge resection of gastric leiomyoma. JSLS (2004) 0.84
Effects of aspirin on gastroduodenal permeability in alcoholics and controls. Alcohol (2010) 0.83
A multicenter retrospective experience of infliximab in Crohn's disease patients: infusion reaction rates and treatment persistency. Gastroenterol Hepatol (N Y) (2007) 0.83
Alcoholic liver disease: is it an "extraintestinal" complication of alcohol-induced intestinal injury? J Lab Clin Med (2003) 0.83
Role for intestinal CYP2E1 in alcohol-induced circadian gene-mediated intestinal hyperpermeability. Am J Physiol Gastrointest Liver Physiol (2013) 0.83
Current therapeutic approaches in inflammatory bowel disease. Curr Pharm Des (2010) 0.83
A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis. Gastroenterology (2006) 0.83
Evidence for non-chemical, non-electrical intercellular signaling in intestinal epithelial cells. Bioelectrochemistry (2007) 0.83
Diagnostic medical radiation in inflammatory bowel disease: how to limit risk and maximize benefit. Inflamm Bowel Dis (2013) 0.82
"Real world" treatment of metastatic renal cell carcinoma in a joint community-academic cohort: progression-free survival over three lines of therapy. Clin Genitourin Cancer (2013) 0.82
Circadian disruption: potential implications in inflammatory and metabolic diseases associated with alcohol. Alcohol Res (2013) 0.82
Symptom Burden for Patients with Metastatic Colorectal Cancer Treated with First-Line FOLFOX or FOLFIRI with and Without Bevacizumab in the Community Setting. Support Cancer Ther (2007) 0.82
Impact of dietary fiber fermentation from cereal grains on metabolite production by the fecal microbiota from normal weight and obese individuals. J Med Food (2013) 0.81
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancer. Breast (2009) 0.81
Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson's disease. Mov Disord (2013) 0.81
New molecular insights into inflammatory bowel disease-induced diarrhea. Expert Rev Gastroenterol Hepatol (2011) 0.81
A multi-scale stochastic drug release model for polymer-coated targeted drug delivery systems. J Control Release (2005) 0.81
Laparoscopic repair of congenital duodenal obstruction. J Laparoendosc Adv Surg Tech A (2006) 0.81
Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients. Health Qual Life Outcomes (2011) 0.80
Willingness to pay to prevent chemotherapy induced nausea and vomiting among patients with breast, lung, or colorectal cancer. J Med Econ (2013) 0.80
Hyperalbuminemia and elevated transaminases associated with high-protein diet. Scand J Gastroenterol (2006) 0.80